文献速递流行病学与生物统计真实世界研究与卫生经济

基于倾向性评分的荟萃分析预测先验:整合真实世界与历史数据

Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data.
PubMed 文献 · Stat Med · 2021-06-14

该文提出将倾向性评分方法与贝叶斯荟萃分析预测(MAP)先验结合,形成PS-MAP先验,用于借用外部真实世界和历史数据。倾向性评分从外部数据中筛选与当前研究关键基线协变量相似的患者并分层,MAP先验获得各层特异性先验并整合为总体PS-MAP先验。模拟研究比较了PS-MAP先验与现有倾向性评分整合功效先验方法,并用单臂II期试验示例说明实施。

要点

  • PS-MAP先验整合倾向性评分与贝叶斯荟萃分析预测先验,借用外部数据。
  • 倾向性评分筛选相似患者并分层,MAP先验获得层特异性及总体先验。
  • 可调节先验有效样本量以量化从外部数据借用的信息量。

核心结论

  • 提出的PS-MAP先验可整合倾向性评分与贝叶斯荟萃分析预测先验,用于借用真实世界和历史数据。

研究设计与样本

  • 方法学文章,提出PS-MAP先验,并通过模拟研究和单臂II期试验示例评估性能。

主要发现

  • 模拟研究比较了PS-MAP先验与现有倾向性评分整合功效先验方法。
  • 单臂II期试验示例展示了PS-MAP先验的实施。

关键数值与推荐

  • 倾向性评分用于从外部数据中筛选与当前研究关键基线协变量相似的患者并分层。
  • MAP先验用于获得层特异性MAP先验并推导总体PS-MAP先验。
  • 允许调节PS-MAP先验的有效样本量以量化借用信息量。

临床怎么用

  • 在单臂试验等场景中,可利用PS-MAP先验整合外部真实世界和历史数据以辅助决策。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

As the availability of real-world data sources (eg, EHRs, claims data, registries) and historical data has rapidly surged in recent years, there is an increasing interest and need from investigators and health authorities to leverage all available information to reduce patient burden and accelerate both drug development and regulatory decision making. Bayesian meta-analytic approaches are a popular historical borrowing method that has been developed to leverage such data using robust hierarchical models. The model structure accounts for various degrees of between-trial heterogeneity, resulting in adaptively discounting the external information in the case of data conflict. In this article, we propose to integrate the propensity score method and Bayesian meta-analytic-predictive (MAP) prior to leverage external real-world and historical data. The propensity score methodology is applied to select a subset of patients from external data that are similar to those in the current study with regards to key baseline covariates and to stratify the selected patients together with those in the current study into more homogeneous strata. The MAP prior approach is used to obtain stratum-specific MAP prior and derive the overall propensity score integrated meta-analytic predictive (PS-MAP) prior. Additionally, we allow for tuning the prior effective sample size for the proposed PS-MAP prior, which quantifies the amount of information borrowed from external data. We evaluate the performance of the proposed PS-MAP prior by comparing it to the existing propensity score-integrated power prior approach in a simulation study and illustrate its implementation with an example of a single-arm phase II trial.

来源:Stat Med,查看原文。版权归原作者所有。

引用

  1. Liu M, Bunn V, Hupf B, et al. Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data. Stat Med. 2021. PMID: 34126656. doi:10.1002/sim.9095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。